Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yaquelin Duncan Roberts"'
Autor:
Irene Rojas Rondón, Lázaro Vigoa Aranguren, Yanelda Garcìa Vega, Iraldo Bello Rivero, Yaquelin Duncan Roberts
Publikováno v:
Revista Cubana de Oftalmología, Vol 34, Iss 1 (2021)
RESUMEN Objetivo: Determinar la respuesta clínica en pacientes con carcinoma basal palpebral tratados con HeberFERON(. Métodos: Se realizó un estudio descriptivo en pacientes con carcinoma basal palpebral, a quienes se les aplicó HeberFERON( peri
Externí odkaz:
https://doaj.org/article/3d634b9ce8884863849729804d53ad56
Autor:
Hugo Nodarse-Cuni, Francisco Hernández-Bernal, Idelsis Esquivel-Moynelo, Bello-Rivero Iraldo, Claudia Martínez Suarez, Gerardo Guillén-Nieto, Yaquelin Duncan-Roberts, Verena Muzio-Gonzalez, Ivan Campa-Legrá
Background: As the outbreak of COVID-19 has accelerated, an urgent need for finding strategies to combat the virus is growing. Results from in vitro studies suggest that a combination of IFN type I and Type II may be effective against SARS-CoV. The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c80ecb1ed9b42f1428ed7dc7d387b23f
https://doi.org/10.21203/rs.3.rs-28958/v2
https://doi.org/10.21203/rs.3.rs-28958/v2
Publikováno v:
Biomedical Journal of Scientific & Technical Research. 30
Single Nucleotide Polymorphism (SNPs) being simplest form of variation promises the assistance for forensic DNA analyses because of an excess of potential markers...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bbb510e19a271f11cc0f48be67a98d7
https://doi.org/10.26717/bjstr.2020.30.004974
https://doi.org/10.26717/bjstr.2020.30.004974
Autor:
Yaquelin Duncan-Roberts, Vladimir Besada-Perez, Iraldo Bello-Rivero, Yanelda Garcia-Vega, Dania Vazquez-Blomquistc, Margarita Rios-Cabrera, Hector Santana-Milian
Publikováno v:
Seminars in Oncology. 45:27-33
The rational combination of recombinant IFN-α2b and IFN-γ resulted in a new formulation of interferons (HeberFERON) with improved pharmacodynamics. In basal cell carcinomas HeberFERON produces a more rapid antitumor effect and results in a larger n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8451d67d30314696b29f3981d61a4e3d
https://doi.org/10.1053/j.seminoncol.2018.04.007
https://doi.org/10.1053/j.seminoncol.2018.04.007
Autor:
Irene Rojas Rondón, Yaquelin Duncan Roberts, Clara Gómez Cabrera, Cuba. Centro de Ingeniería Genética y Biotecnología. La Habana, Ramón Pando Ferrer, Lázara Kenia Ramírez García, Lázaro Vigoa Aranguren, Ángela D. Tuero Iglesias, Cuba. Grupo Empresarial Labiofam. La Habana, Iraldo Bello Rivero, Reinier Hernández Rodríguez
Publikováno v:
Bionatura, Vol 1, Iss 2, Pp 71-74 (2016)
Cancer is once again the first cause of death in Cuba, and currently among the Latin-American countries and the third world, thus according to estimates, our country has the highest incidence rate of non-melanoma skin cancer. The Basal cell carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c540cfebb80a9760bdb4853aa64adc
https://doi.org/10.21931/rb/2016.01.02.6
https://doi.org/10.21931/rb/2016.01.02.6
Publikováno v:
MEDICC review. 20(1)
SUMMARY INTRODUCTION Interferons have been used to treat basal cell carcinoma with positive results. Cuba’s Genetic Engineering and Biotechnology Center developed HeberPAG, a combined formulation of interferons alpha-2b and gamma, for treatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ffd162b47cb8ffb74a7935c137c9c3c
https://pubmed.ncbi.nlm.nih.gov/34229416
https://pubmed.ncbi.nlm.nih.gov/34229416
Autor:
Carmen Valenzuela Silva, Yoddali Ballester Caballero, Yaquelin Duncan Roberts, Lorenzo Anasagasti Angulo, Yanelda Garcia Vega, Jorge Marin Guerra, Katherine Batista, Ángela D. Tuero Iglesias, Edgar Tijerino Arrieta, Yanisel Jiménez Barbán, Leovaldo Alvarez Falcon, Iraldo Bello Rivero, Vladimir Sánchez Linares, Sonia Collazo
Publikováno v:
Australasian Medical Journal, Vol 10, Iss 6, Pp 509-515 (2017)
Background Surgery remains the procedure of election for the treatment of non-melanoma skin cancer (NMSC). However, after recurrence, or under surgical complex scenarios, other therapeutic modalities have to be indicated. Immune suppression is associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8b3c6e47f4d7b0a9d8abe1aa3fc06d
https://doi.org/10.21767/amj.2017.3013
https://doi.org/10.21767/amj.2017.3013
Autor:
Iraldo Bello-Rivero, Dania Vazquez-Blomquist, Mileidys Cabrera-Placeres, Yoandy Izquierdo-Toledo, Tania I Carballo-Treto, Idrian García-García, Nailet Castro-Basart, Josanne Soto-Matos, Yaquelin Duncan-Roberts, Sonia E Collazo-Caballero, Elizeth García-Iglesias, Egla E Santely-Pravia, Alieski Cruz-Ramírez, Cristian Alfonso-Alvarado, Ángela D. Tuero-Iglesias, Yanelda García-Vega
Publikováno v:
BMC Pharmacology & Toxicology
Background The synergistic combination of interferon (IFN) alpha-2b and IFN gamma results in more potent in vitro biological effects mediated by both IFNs. The aim of this investigation was to evaluate by first time the pharmacokinetics and pharmacod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca8c2c8964f3de88fe55c00ca393ecc
https://doi.org/10.1186/2050-6511-13-20
https://doi.org/10.1186/2050-6511-13-20
Autor:
Irene Rojas Rondón, Lázaro Vigoa Aranguren, Yanelda García Vega, Iraldo Bello Rivero, Yaquelín Duncan Roberts
Publikováno v:
Revista Cubana de Oftalmología, Vol 34, Iss 1 (2021)
RESUMEN Objetivo: Evaluar la seguridad del HeberFERON( en el tratamiento del carcinoma basal palpebral. Métodos: Se realizó un estudio descriptivo en pacientes con carcinoma basal palpebral, a quienes se les aplicó HeberFERON( perilesional, de ene
Externí odkaz:
https://doaj.org/article/65603180c9d74cecba44e056f74b344b